As of June 21, 2025, Twinlab Consolidated Holdings Inc (TLCC) reports a Gross Margin of 36.81%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Twinlab Consolidated Holdings Inc's Gross Margin
Over recent years, Twinlab Consolidated Holdings Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2023-12-31 | 36.81% |
| 2022-12-31 | 82.84% |
| 2021-12-31 | 23.00% |
| 2020-12-31 | 16.40% |
| 2019-12-31 | 15.23% |
This slight downward trend highlights how Twinlab Consolidated Holdings Inc manages its operational efficiency and pricing power over time.
Comparing Twinlab Consolidated Holdings Inc's Gross Margin to Peers
To better understand Twinlab Consolidated Holdings Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Twinlab Consolidated Holdings Inc (TLCC) | 36.81% |
| Baikang Biological Group Holdings Ltd (BKSW) | 76.27% |
| Bhang Inc (BHNG.CN) | 66.46% |
| CCA Industries Inc (CAWW) | 64.75% |
| Gilla Inc (GLLA) | 64.34% |
| China Botanic Pharmaceutical Inc (CBPI) | 59.39% |
Compared to its competitors, Twinlab Consolidated Holdings Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.